thumb_97260.png
Promising News For Those Facing an Aggressive Form of Lung Cancer
SEE MORE

Promising News For Those Facing an Aggressive Form of Lung Cancer

Lung cancer is the leading cause of cancer death among both men and women and accounts for about one-quarter of all cancer deaths in the US: more than breast, prostate and colorectal cancers combined. One of the most aggressive forms of the disease is small cell lung cancer (SCLC), which makes up about 15% of lung cancer cases in the U.S. Although SCLC is less common (non-small cell lung cancer makes up about 85% of lung cancer cases), it is fast-growing and spreads more rapidly to other parts of the body. Almost two-thirds of diagnosed patients have extensive-stage disease when the cancer is first found, meaning the cancer has already spread to both lungs or other more distant parts of the body. Patients with extensive-stage small cell lung cancer (ES-SCLC) face a particularly poor prognosis and are in urgent need of new options.

Dr. Yuanbin Chen, Oncologist at Cancer & Hematology Centers of Western Michigan, is discussing new data being released surrounding the treatment of extensive-stage small cell lung cancer as well as why more attention is needed in this area of lung cancer.

For more information:
Imfinzi.com
Cancer.org

col1_vertical_list_trending